We have used a fluorescence in situ hybridisation (FISH) ETV1 gene ‘break-apart’ assay to screen for ETV1 rearrangements on a Tissue Microarray (TMA) consisting of 945 trans-urethral resection of the prostate cancer cores from 429 patients. This evidence concerns the gene ETV1 and prostate carcinoma.